Skip to main content

SHADAC Resource on Required Evaluation Plans for DSRIP/Delivery System Reforms through 1115 Waivers

Madelyn Klabunde, Research Assistant
October 11, 2019

Introduction
SHADAC researchers have extensive experience providing technical assistance to states on payment and delivery system reform, often supporting the evaluation and monitoring of these activities. Recently, we have been working with a subset of states pursuing innovative policies under the Medicaid 1115 waiver opportunity, which requires a rigorous independent evaluation. To support peer learning around the evaluation of delivery and payment reform, SHADAC has reviewed publicly available evaluation plans related to one waiver type, the Delivery System Reform Incentive Payment (DSRIP) programs, and created a resource summarizing state evaluation approaches.  

Delivery System Reform Incentive Payment Programs[1]
Delivery System Reform Incentive Payment (DSRIP) programs are a subset of Medicaid 1115 waiver initiatives that aim to improve a state’s healthcare delivery system through performance-based payments to hospital systems and providers. The Centers for Medicare and Medicaid Services (CMS) approved the first DSRIP waiver in 2010.[2] At their core, DSRIP waivers provide incentive payments to hospitals and other providers to support various projects aimed at improving care quality and patient outcomes and reducing cost. To participate in the program, healthcare organizations pick from a menu of projects (crafted by CMS in collaboration with the state) to implement and evaluate within their system. Payments are made to providers based on milestones that are met and quality improvement achievements. Under this construct, CMS and states assume that the value added by systems, infrastructure, and payment reforms will outweigh the costs of implementation and incentive payment.

DSRIP Evaluation Activities and Requirements
There are both federal-led and state-led evaluations of DSRIP programs. At the federal level, CMS has contracted with Mathematica Policy Research to produce meta-analyses, case studies, and implementation reports for many 1115 waiver strategies, including specific evaluations of DSRIP programs.[3] Notably, CMS published two separate but related analyses of the implementation of DSRIP progress and outcome measurement and of key DSRIP demonstration design strategies to reward performance, as well as an Interim Evaluation Report of existing DSRIP demonstrations. Most recently, CMS published its approach to the final outcomes evaluation for DSRIP programs approaching conclusion.[4] In addition, CMS has developed state-level independent evaluation guidelines for states pursuing a variety eligibility, coverage, and delivery system reform waivers. States, including those with DSRIP waivers, are required to adhere to these evaluation guidelines and report regularly on both their monitoring and evaluation efforts.  

SHADAC’s Catalogue of DSRIP Evaluation Plans
With CMS’s heightened expectations and improved guidance for program evaluation, SHADAC felt that reviewing state evaluations of DSRIP programs could serve as a useful learning opportunity for states interested in delivery reform or other systems change efforts.[5] We have summarized these activities in a resource that includes program characteristics as well as evaluation design characteristics being used in the seven states for which evaluation plans or reports are publicly available. Evaluation design characteristics include:

  • Program Implementation Timeframe
  • State and Federal Funding
  • Timeline for Evaluation Deliverables
  • Evaluation Characteristics (Budget, contractor, logic model)
  • Evaluation Methods (Qualitative Analysis, Randomized Controlled Trial, etc.)
  • Evaluation Comparison Group Levels (Beneficiary, Program, Provider, Project, etc.)
  • Beneficiary Comparison Groups
  • Secondary Data Sources
  • Primary and Qualitative Data Sources

States can use this resource in the following ways: 

  • Search for programs implementing similar reforms and learn more about evaluation approaches.
  • Identify whether there are any available evaluation reports.
  • Learn independent contractor budgets.
  • Determine whether states are proposing control groups in the event that a state is interested in reaching out to learn more details about the success of the approach.
  • Determine whether states are proposing randomized control trials.

SHADAC used the following approach to selecting states for inclusion in the catalogue. We cross-referenced MACPAC’s summary of existing DSRIP or DSRIP-like waivers[6] with CMS’s federal evaluator’s list of DSRIP programs. We also confirmed that these states were in the Kaiser Family Foundation’s Medicaid Waiver Tracker.[7] To investigate how states are evaluating their DSRIP initiatives, we looked for evaluation designs published by the DSRIP states of interest on both CMS’s state waiver repository and state government websites. According to federal guidance, evaluation plans should be submitted to CMS within 180 days of waiver approval, and posted publicly within 30 days of evaluation plan approval. Of the DSRIP and DSRIP-like states, we identified seven states with publicly accessible and approved evaluation designs—California, Massachusetts, New Hampshire, New York, Oregon, Texas, and Washington. The work of three states (MA, CA, and TX) pre-dates the implementation of the Affordable Care Act in 2014.

SHADAC Resource on Required Evaluation Plans for DSRIP / Delivery System Reforms Through 1115 Waivers
  CALIFORNIA MASSACHUSETTS NEW HAMPSHIRE NEW YORK OREGON TEXAS WASHINGTON
Program Public Hospital Redesign Incentives in
Medi-Cal (PRIME)
Delivery System Reform Incentive Payment Building Capacity for Transformation Medicaid Redesign Team Waiver Amendment* Oregon Health Plan (formerly Hospital Transformation Performance) Program Healthcare Transformation and Quality Improvement Program**  Transformation 
through Accountable Communities of Health
Program Implementation  2010-2015 (DSRIP);
2016-2020 (PRIME)
2011-2017 (DSTI);
2017-2022 6th waiver extension (DSRIP)
2016-2020 2014-2019  2014-2018 (HTPP, DSRIP-like); 2017-2022  2011-2017 (DSRIP); 2017-2022 (DSRIP renewal & final funding) 2017-2021
State and Federal Funding $7.46 billion (PRIME) $1.80 billion (DSRIP) $150 million  $12.84 billion  $600 million $10.83 billion (renewal) $1.13 billion 
Program Description Performance-based funding made available to PRIME entities, which include California's Designated Public Hospitals and Municipal Public Hospitals for implementation of projects in three domains (outpatient delivery system reform, targeted high risk or high cost, and resource utilization efficiency) and demonstration of improved outcomes, such as clinical event outcomes, potentially preventable events, and patient experience measures. Supports the implementation of three ACO models, the formation and payment of Behavioral Health and Long Term Services and Supports Community Partners and Community Service Agencies, and statewide infrastructure, workforce capacity, and operations to enable successful reform implementation. Performance-based funding made available to seven regionally based Integrated Delivery Networks (IDNs), which are required to implement six integrated physical and behavioral health care projects to improve coordination and linkages, reduce gaps, and meet needs of beneficiaries with behavioral health disorders. Formation of 25 Performing Provider Systems (PPS) offering targeted, integrated care, which is incentivized through value-based payments. Extension of Oregon's performance incentive program for Medicaid coordinated care organizations (CCOs) allowing diagnostic-related group (DRG) hospitals (i.e., larger, urban hospitals) to earn incentive payments for reporting and improving their performance on select quality measures. Three components of the waiver, one of which relates to delivery system reform (two other components include Medicaid Managed Care expansion and Uncompensated Care Pool). Delivery system reform calls for performance-based incentive payments made available to provider members of Regional Healthcare Partnerships for implementation of projects and demonstration of increased access to, coordination and quality care and improved outcomes. Performance-based funding made available to nine regionally-based Accountable 
Communities of Health (ACHs), which are self-governing organizations with multiple partners responsible for managing and coordinating evidence-based projects to transform care delivery and improve health.
CMS Evaluation Deliverable Timeline  - Planned
Evaluation Design Approved 8/23/2017 1/31/2019 9/5/2017 3/13/2018 2/14/2018 8/2/2018 10/26/2017
Interim Evaluation Report Due 3/30/2019 6/30/2021 8/21/2019 6/30/2019 6/30/2021 3/28/2022 8/1/2021
Summative Evaluation Report Due 12/31/2021 12/31/2023 2/23/2022 3/28/2021 12/31/2023 9/18/2024 5/30/2022
CMS Evaluation Report Available       X      
Other State Monitoring or Evaluation Reports Available Final Evaluation - Bridge to Reform, DSRIP     2018 Statewide Annual Report for the NEW YORK STATE Delivery System Reform Incentive Payment (DSRIP) Program Oregon Hospital Transformation Performance Program Year 4 Performance Previous DSRIP Cycle - Final Evaluation-  Healthcare Transformation and Quality Improvement  
Evaluation Characteristics
Logic Model X X X     X  
Evaluation Contractor UCLA Center for Health Policy Research University of Maryland Medical System TBD Research Foundation of the State University of New York (SUNY), Institute for Health System Evaluation Oregon Health and Science University, Center for Health Systems Effectiveness   Texas University TBD
Evaluation Subcontractor       University at Albany, SUNY; Boston University School of Public Health; University of Maryland School of Public Health Providence Center for Outcomes Research and Education    
Budget $2.2 million $6 million $2 million Not publicly available $650,000 $6 million (all components) Over $4 million
Evaluation Methods
Qualitative analysis X X X X X X X
Randomized, controlled trial              
Quasi-experimental (e.g., difference in differences, hierarchical linear models, or interrupted time series) X X X X   X X
Descriptive statistics X X X   X X X
Cost effectiveness/ROI   X   X      
Social network analysis           X  
Evaluation Comparisons
Beneficiary level   X X X X X X
Program/provider or network/project level X X   X   X X
Subgroups   X X       X
Beneficiary-level Comparison Groups
Propensity score or exact or distance matched X X   Planned     X
Pre-intervention or baseline group X X X Planned X   X
Beneficiaries or providers not participating in program       X   X  
Beneficiaries with no BH disorders     X        
Secondary Data Sources
Medicaid administrative data, including claims, eligibility, enrollment, demonstration monitoring data X X X X X X X
Medicare administrative data       X      
All-payer claims data     X X X    
Other non-Medicaid or Medicare program data (e.g., mental health, substance use, social or human services, emergency department data)   X   X   X X
Non-claim discharge data (e.g., NH psychiatric hospital, MA safety net hospital and uncompensated care cost reports)   X X     X  
Medical records X     X X    
Vital records   X   X     X
Census data (e.g., ACS, CPS)   X   X X    
Registry data         X   X
EDIE         X    
HEDIS     X       X
CAHPS       X X   X
BRFFS     X X      
Other (e.g., WA Pregnancy Risk Assessment Monitoring System, MA opioid overdose data)   X         X
Primary and Qualitative Data Sources
Document review X X X X X X X
Literature review       X      
Beneficiary surveys   X X X X   X
Provider surveys X X X X   X X
Stakeholder interviews X X X X X X X
Stakeholder focus groups       X X   X
Site visits/case studies   X          
*Information from state is from the evaluation report, NOT the evaluation design plan. 
**Evaluation plans relate to the delivery system component of the waiver only.

 

If you have feedback on the usefulness of this catalogue, or have an interest in seeing a catalogue like this for other program types, please contact SHADAC at shadac@umn.edu.


[1] Gates, A., Rudowitz, R., & Guyer, J. (2014, September 29). An Overview of Delivery System Reform Incentive Payment (DSRIP) Waivers [PDF file]. Retrieved from https://www.kff.org/medicaid/issue-brief/an-overview-of-delivery-system-reform-incentive-payment-waivers/
[2] Medicaid and CHIP Payment and Access Commission (MACPAC). (2018). Delivery System Reform Incentive Payment Programs. Retrieved from https://www.macpac.gov/wp-content/uploads/2018/03/Delivery-System-Reform-Incentive-Payment-Programs.pdf
[3] Center for Medicare and Medicaid Services (CMS). (2019). 1115 Demonstration Federal Evaluation and Meta-Analysis. Retrieved from https://www.medicaid.gov/medicaid/section-1115-demo/evaluation-reports/federal-evaluation-and-meta-analysis/index.html
[4] Baller, J., Verbitsky Savitz, N., & Heeringa, J. (2019). Delivery System Reform Incentive Payments. Retrieved from https://www.medicaid.gov/medicaid/section-1115-demo/downloads/evaluation-reports/final-eval-dsgn-dlvry-incntv-pyments.pdf
[5] While DSRIP programs appear to be phasing out of popularity and existing waivers are soon to wrap up, the concepts behind the creation of DSRIP programs continue to be tested under different initiatives. Hinton, E., Musumeci, M., Rudowitz, R., Antonisse, L., & Hall, C. (2019, February 12). Section 1115 Medicaid Demonstration Waivers: The Current Landscape of Approved and Pending Waivers [PDF file]. Retrieved from https://www.kff.org/medicaid/issue-brief/section-1115-medicaid-demonstration-waivers-the-current-landscape-of-approved-and-pending-waivers/
[6] Medicaid and CHIP Payment and Access Commission (MACPAC). (2018). Delivery System Reform Incentive Payment Programs. Retrieved from https://www.macpac.gov/wp-content/uploads/2018/03/Delivery-System-Reform-Incentive-Payment-Programs.pdf
[7] Kaiser Family Foundation (KFF). (2019, September 18). Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State. Retrieved from https://www.kff.org/medicaid/issue-brief/medicaid-waiver-tracker-approved-and-pending-section-1115-waivers-by-state/